(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors

Michael Maes; Brian Leonard; Alberto Fernandez; Marta Kubera; Gabriel Nowak; Rob Veerhuis; Ann Gardner; Piaynuj Ruckoanich; Michel Geffard; Carlo Altamura; Piotr Galecki; Michael Berk

doi:10.1016/j.pnpbp.2011.02.019

(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors

Michael Maes, Brian Leonard, Alberto Fernandez, Marta Kubera, Gabriel Nowak, Rob Veerhuis, Ann Gardner, Piaynuj Ruckoanich, Michel Geffard, Carlo Altamura, Piotr Galecki, Michael Berk

Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	659-663
Number of pages	5
Journal	Progress in Neuro-Psychopharmacology and Biological Psychiatry
Volume	35
Issue number	3
DOIs	https://doi.org/10.1016/j.pnpbp.2011.02.019
Publication status	Published - Apr 29 2011

ASJC Scopus subject areas

Biological Psychiatry
Pharmacology

Access to Document

10.1016/j.pnpbp.2011.02.019

Cite this

Maes, M., Leonard, B., Fernandez, A., Kubera, M., Nowak, G., Veerhuis, R., Gardner, A., Ruckoanich, P., Geffard, M., Altamura, C., Galecki, P., & Berk, M. (2011). (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(3), 659-663. https://doi.org/10.1016/j.pnpbp.2011.02.019

Maes, M, Leonard, B, Fernandez, A, Kubera, M, Nowak, G, Veerhuis, R, Gardner, A, Ruckoanich, P, Geffard, M, Altamura, C, Galecki, P & Berk, M 2011, '(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors', Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 3, pp. 659-663. https://doi.org/10.1016/j.pnpbp.2011.02.019

@article{29e9b0baaf124356b79a82390bbbfbbf,

title = "(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors",

author = "Michael Maes and Brian Leonard and Alberto Fernandez and Marta Kubera and Gabriel Nowak and Rob Veerhuis and Ann Gardner and Piaynuj Ruckoanich and Michel Geffard and Carlo Altamura and Piotr Galecki and Michael Berk",

year = "2011",

month = apr,

day = "29",

doi = "10.1016/j.pnpbp.2011.02.019",

language = "English",

volume = "35",

pages = "659--663",

journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",

issn = "0278-5846",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression

T2 - From antioxidants to kinase inhibitors

AU - Maes, Michael

AU - Leonard, Brian

AU - Fernandez, Alberto

AU - Kubera, Marta

AU - Nowak, Gabriel

AU - Veerhuis, Rob

AU - Gardner, Ann

AU - Ruckoanich, Piaynuj

AU - Geffard, Michel

AU - Altamura, Carlo

AU - Galecki, Piotr

AU - Berk, Michael

PY - 2011/4/29

Y1 - 2011/4/29

UR - http://www.scopus.com/inward/record.url?scp=79954592668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954592668&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2011.02.019

DO - 10.1016/j.pnpbp.2011.02.019

M3 - Article

C2 - 21376099

AN - SCOPUS:79954592668

SN - 0278-5846

VL - 35

SP - 659

EP - 663

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

IS - 3

ER -

(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this